These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23636824)

  • 21. An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection.
    Ni Y; Guo J; Turner D; Tizard I
    Front Immunol; 2018; 9():1815. PubMed ID: 30140267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.
    Skehel JJ; Wiley DC
    Annu Rev Biochem; 2000; 69():531-69. PubMed ID: 10966468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
    Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
    J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural transitions in influenza haemagglutinin at membrane fusion pH.
    Benton DJ; Gamblin SJ; Rosenthal PB; Skehel JJ
    Nature; 2020 Jul; 583(7814):150-153. PubMed ID: 32461688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. pH-induced conformational changes of membrane-bound influenza hemagglutinin and its effect on target lipid bilayers.
    Gray C; Tamm LK
    Protein Sci; 1998 Nov; 7(11):2359-73. PubMed ID: 9828002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epitope analysis of the hemagglutinin molecule of the Victoria lineage influenza B viruses].
    Sorokin EV; Tsareva TR; Sominina AA; Pisareva MM; Komissarov AV; Kosheleva AA; Grudinin MP
    Vopr Virusol; 2014; 59(6):27-31. PubMed ID: 25929033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural Basis for the Broad, Antibody-Mediated Neutralization of H5N1 Influenza Virus.
    Lin Q; Li T; Chen Y; Lau SY; Wei M; Zhang Y; Zhang Z; Yao Q; Li J; Li Z; Wang D; Zheng Q; Yu H; Gu Y; Zhang J; Chen H; Li S; Xia N
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An antibody that prevents the hemagglutinin low pH fusogenic transition.
    Barbey-Martin C; Gigant B; Bizebard T; Calder LJ; Wharton SA; Skehel JJ; Knossow M
    Virology; 2002 Mar; 294(1):70-4. PubMed ID: 11886266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
    Khurana S; Loving CL; Manischewitz J; King LR; Gauger PC; Henningson J; Vincent AL; Golding H
    Sci Transl Med; 2013 Aug; 5(200):200ra114. PubMed ID: 23986398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
    He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
    J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site.
    Fleury D; Barrère B; Bizebard T; Daniels RS; Skehel JJ; Knossow M
    Nat Struct Biol; 1999 Jun; 6(6):530-4. PubMed ID: 10360354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and Structure of an Engineered Disulfide-Stabilized Influenza Virus Hemagglutinin Trimer.
    Lee PS; Zhu X; Yu W; Wilson IA
    J Virol; 2015 Jul; 89(14):7417-20. PubMed ID: 25926650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
    Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice.
    van der Lubbe JEM; Verspuij JWA; Huizingh J; Schmit-Tillemans SPR; Tolboom JTBM; Dekking LEHA; Kwaks T; Brandenburg B; Meijberg W; Zahn RC; Roozendaal R; Kuipers H
    Front Immunol; 2018; 9():2350. PubMed ID: 30369928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
    Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
    J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies.
    Varecková E; Mucha V; Wharton SA; Kostolanský F
    Arch Virol; 2003 Mar; 148(3):469-86. PubMed ID: 12607099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monoclonal antibodies with high virus-neutralizing activity against pandemic influenza virus A/llV-Moscow/01/2009 (H1N1)swl].
    Klimova RR; Masalova OV; Burtseva EI; Chichev EV; Lesnova EI; Oskerko TA; Mukasheva EA; Rudneva IA; Lvov DK; Kushch AA
    Vopr Virusol; 2011; 56(3):15-20. PubMed ID: 21786621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conserved stem fragment from H3 influenza hemagglutinin elicits cross-clade neutralizing antibodies through stalk-targeted blocking of conformational change during membrane fusion.
    Gong X; Yin H; Shi Y; Guan S; He X; Yang L; Yu Y; Kuai Z; Jiang C; Kong W; Wang S; Shan Y
    Immunol Lett; 2016 Apr; 172():11-20. PubMed ID: 26875772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses.
    Boonsathorn N; Panthong S; Koksunan S; Chittaganpitch M; Phuygun S; Waicharoen S; Prachasupap A; Sasaki T; Kubota-Koketsu R; Yasugi M; Ono K; Arai Y; Kurosu T; Sawanpanyalert P; Ikuta K; Watanabe Y
    Biochem Biophys Res Commun; 2014 Sep; 452(3):865-70. PubMed ID: 25204499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Energetics of the loop-to-helix transition leading to the coiled-coil structure of influenza virus hemagglutinin HA2 subunits.
    Huang Q; Korte T; Rachakonda PS; Knapp EW; Herrmann A
    Proteins; 2009 Feb; 74(2):291-303. PubMed ID: 18618705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.